Clinical Trial and Real-World Outcomes of Patients With Metastatic NSCLC in the Post-Platinum–Based Chemotherapy Failure Setting
Introduction: A literature review was undertaken to identify clinical trials and real-world studies of patients with stage IV NSCLC who had progressed on or after treatment with platinum-based chemotherapy. Methods: The EMBASE and MEDLINE databases were used to search for English-language studies pu...
Main Authors: | Yu Yang Soon, MBBS, Wesley Furnback, BA, Jin Kim, MS, Po-Ya Chuang, MHA, Gordon Chavez, BA, Christina Proescholdt, MD, Cloe Ying Chee Koh, MS |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-11-01
|
Series: | JTO Clinical and Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364323001224 |
Similar Items
-
Establishing a Prediction Model for the Efficacy of Platinum—Based Chemotherapy in NSCLC Based on a Two Cohorts GWAS Study
by: Qi Xiao, et al.
Published: (2023-02-01) -
Health-Related Quality of Life for Patients Receiving Tumor Treating Fields for Glioblastoma
by: Joshua D. Palmer, et al.
Published: (2021-12-01) -
Management of Oligoprogression in Patients with Metastatic NSCLC Harboring ALK Rearrangements
by: Chiara Pisano, et al.
Published: (2022-01-01) -
Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC
by: Pingyu Chen, et al.
Published: (2022-08-01) -
Amivantamab-Vmjw: A Novel Treatment for Patients with NSCLC Harboring EGFR Exon 20 Insertion Mutation after Progression on Platinum-Based Chemotherapy
by: Vishal Shah, et al.
Published: (2023-03-01)